{"database": "lobbying", "table": "lobbying_activities", "rows": [[4284653, "b150fc01-f823-426d-aefb-f780f199435e", "3T", "ACCENDRA HEALTH INC.", 401105919, "ACCENDRA HEALTH INC.", 2026, "third_quarter", "MMM", "Issues related to access to home medical equipment and related reimbursement (i.e., \"Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act\" (S. 4037) and \"DMEPOS Relief Act of 2025\" [H.R. 2005, S. 2951]; and competitive bidding, \"Supplemental Oxygen Access Reform [SOAR] Act of 2025\" [H.R. 2902, S. 1406]); \"DME Scammer Prevention (H.R. 8871)\"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.", "HOUSE OF REPRESENTATIVES,SENATE", 0, 1, "2026-09-28T08:16:54-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["4284653"], "units": {}, "query_ms": 0.2411622554063797, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}